A weight-maintaining hormone is essential for brain-signal transmission. New research is more closely linking obesity to ...

A recent analysis investigated the state of metabolic disruption experienced by patients with spinal muscular atrophy (SMA), ...

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) shares are moving lower Friday after the Committee for Medicinal Products for ...

Differences in SMA newborn screening practices in the U.S. could impact referral patterns or the timing of therapeutic ...

Findings suggest Mediterranean and green-MED diets improve brain health, with polyphenols contributing to younger brain age ...

The decision against Syfovre’s approval follows efforts by Apellis to have reviewers reevaluate clinical evidence multiple times and, according to an analyst, will lead to a restructuring of the ...

Apellis Pharmaceuticals, Inc. (APLS) announced on Friday that the Committee for Medicinal Products for Human Use or CHMP of the ...

Acute optic neuritis induced visual impairment can be predicted by presenting damage to anterior and posterior cortical visual pathways.

The CHMP initially adopted a negative opinion in January after finding it was unable to establish a positive balance of benefits and risks for Syfovre, but Apellis sought a re-examination and was able ...

This CHMP opinion was made despite broad support for pegcetacoplan from the European retina community and multiple dissenting votes by CHMP members who supported a path to approval.” “We have seen the ...

New research is more closely linking obesity to dementia. Higher levels of leptin, a hormone that helps maintain normal body ...

Despite enormous effort, disease-modifying therapies for Alzheimer's disease, the most common cause of dementia, have proven ...